Upregulated microRNA‑143 inhibits cell proliferation in human nasopharyngeal carcinoma

He,Benfu; Xu,Zhe; Chen,Jinzhang; Zheng,Dayong; Li,Aimin; Zhang,Luo‑Sheng

doi:10.3892/ol.2016.5363

Upregulated microRNA‑143 inhibits cell proliferation in human nasopharyngeal carcinoma

Authors:
- Benfu He
- Zhe Xu
- Jinzhang Chen
- Dayong Zheng
- Aimin Li
- Luo‑Sheng Zhang
View Affiliations

Affiliations: Department of Oncology, PLA421 Hospital, Guangzhou, Guangdong 510318, P.R. China, Department of Pediatric Surgery, First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China, Department of Oncology, Integrated Chinese and Western Medicine Hospital, Southern Medical University, Guangzhou, Guangdong 510310, P.R. China, Department of Oncology, PLA458 Hospital, Guangzhou, Guangdong 510080, P.R. China
Published online on: November 8, 2016 https://doi.org/10.3892/ol.2016.5363
Pages: 5023-5028
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the possible functions and mechanism of microRNA (miR)‑143 in cell proliferation of human nasopharyngeal carcinoma (NPC). The expression of miR‑143 in NPC cells and tissues was investigated using reverse transcription‑quantitative polymerase chain reaction. Cell viability assay, colony formation assay and flow cytometry were used to examine the cell proliferative ability and tumorigenicity. The expression levels of p21Cip1, p27Kip1, cyclin D1, phosphorylated (p)‑retinoblastoma protein (Rb), Rb and cyclin‑dependent kinase (CDK) 6 were determined by western blotting. Luciferase assay was used to confirm whether CDK6 was a direct target of miR‑143. miR‑143 was downregulated in NPC cell lines and tissues. Overexpression of miR‑143 in NPC CNE1 cells inhibited proliferation, tumorigenicity and cell cycle progression. Additionally, ectopic expression of miR‑143 downregulated cyclin D1 and p‑Rb expression, and upregulated p21Cip1 and p27Kip1 expression, which subsequently inhibited NPC cell proliferation. It was also observed that CDK6 was a direct target of miR‑143, which downregulated CDK6 expression. CDK6 suppression by miR‑143 was associated with dysregulated expression of p21Cip1, p27Kip1, cyclin D1 and p‑Rb, thereby serving an essential role in NPC cell growth. Our findings suggest that miR‑143 inhibits proliferation by targeting CDK6, and may aid to identify new targets for anti-oncomiRs.

View Figures

View References

1	Chen HK, Liu XQ, Lin J, Chen TY, Feng QS and Zeng YX: Mutation analysis of KLF6 gene in human nasopharyngeal carcinomas. Ai Zheng. 21:1047–1050. 2002.(In Chinese). PubMed/NCBI
2	Lo KW and Huang DP: Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol. 12:451–462. 2002. View Article : Google Scholar : PubMed/NCBI
3	Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
4	Macfarlane LA and Murphy PR: MicroRNA: Biogenesis, function and role in cancer. Curr Genomics. 11:537–561. 2010. View Article : Google Scholar : PubMed/NCBI
5	Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
6	Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
7	Kim VN and Nam JW: Genomics of microRNA. Trends Genet. 22:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
8	Olena AF and Patton JG: Genomic organization of microRNAs. J Cell Physiol. 222:540–545. 2010.PubMed/NCBI
9	Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
10	Cho WC: OncomiRs: The discovery and progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
11	Zhong W, He B, Zhu C, Xiao L, Zhou S and Peng X: MiR-143 inhibits migration of human nasopharyngeal carcinoma cells by negatively regulating GLI3 gene. Nan Fang Yi Ke Da Xue Xue Bao. 33:1057–1061. 2013.(In Chinese). PubMed/NCBI
12	Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, et al: Identification of miRs-143 and −145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One. 6:e203412011. View Article : Google Scholar : PubMed/NCBI
13	Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY and Sun XF: Clinicopathological significance of microRNA-31, −143 and −145 expression in colorectal cancer. Dis Markers. 26:27–34. 2009. View Article : Google Scholar : PubMed/NCBI
14	Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and −145 in human gastric cancers. Oncology. 77:12–21. 2009. View Article : Google Scholar : PubMed/NCBI
15	Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, Naoe T and Akao Y: MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 307:211–220. 2011. View Article : Google Scholar : PubMed/NCBI
16	Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One. 6:e284232011. View Article : Google Scholar : PubMed/NCBI
17	Medema RH, Kops GJ, Bos JL and Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature. 404:782–787. 2000. View Article : Google Scholar : PubMed/NCBI
18	Kozar K and Sicinski P: Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle. 4:388–391. 2005. View Article : Google Scholar : PubMed/NCBI
19	Malumbres M and Barbacid M: Cell cycle, CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166. 2009. View Article : Google Scholar : PubMed/NCBI
20	Wang X, Wu J, Lin Y, Zhu Y, Xu X, Xu X, Liang Z, Li S, Hu Z, Zheng X and Xie L: MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6. J Exp Clin Cancer Res. 33:692014. View Article : Google Scholar : PubMed/NCBI
21	Zhang J, Wang L, Li B, Huo M, Mu M, Liu J and Han J: miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells. Exp Ther Med. 8:591–594. 2014.PubMed/NCBI
22	Kikkawa N, Kinoshita T, Nohata N, Hanazawa T, Yamamoto N, Fukumoto I, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y and Seki N: microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma. Int J Oncol. 44:2085–2092. 2014.PubMed/NCBI
23	Honeywell DR, Cabrita MA, Zhao H, Dimitroulakos J and Addison CL: miR-105 inhibits prostate tumour growth by suppressing CDK6 levels. PLoS One. 8:e705152013. View Article : Google Scholar : PubMed/NCBI
24	Xu YF, Li YQ, Guo R, He QM, Ren XY, Tang XR, Jia WH, Kang TB, Zeng MS, Sun Y, et al: Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling. Int J Biochem Cell Biol. 61:120–128. 2015. View Article : Google Scholar : PubMed/NCBI
25	Wang W, Wu S, Shi Y, Miao Y, Luo X, Ji M, Yao K and He J: c-MYB regulates cell growth and DNA damage repair through modulating MiR-143. FEBS Lett. 589:555–564. 2015. View Article : Google Scholar : PubMed/NCBI
26	Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, et al: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet. 39:99–105. 2007. View Article : Google Scholar : PubMed/NCBI
27	Fasano CA, Dimos JT, Ivanova NB, Lowry N, Lemischka IR and Temple S: shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell. 1:87–99. 2007. View Article : Google Scholar : PubMed/NCBI